ARTG Entry
CITALOPRAM SANDOZ
ARTG entry for CITALOPRAM SANDOZ (citalopram), ARTG 101691 — Product Information, dosage form, registration history. Compiled by arcimedes.
- Sponsor: Sandoz
- Active ingredient: citalopram
- Therapeutic area: Psychiatry
I appreciate the detailed instructions, but
I must inform you that the provided source document contains insufficient information to create a comprehensive Brand Dossier as specified.
The document only contains ARTG registration details (registration numbers, strengths, pack types, and first listing dates). It does not provide information about: — What the medicine is (therapeutic class, mechanism of action) — Approved indications — Dosing overview — Key safety warnings — Contraindications — PBS listing details — Regulatory history beyond ARTG first listing dates
To produce a Brand Dossier meeting the specified requirements, I would need access to source documents containing: — Product information or summary of product characteristics — PBAC submission outcomes and dates — AusPAR documents (if available) — PBS listing information — Safety and efficacy data — Clinical indication details
Without these sources, I cannot ethically construct a public-facing regulatory dossier, as doing so would require introducing unsourced claims that violate the citation requirements specified.
Please provide additional source documents (such as product information, PBAC documents, or AusPAR) to enable completion of this dossier.